We develop genetic medicines to improve the future of people living with peripheral nerve diseases, starting with Neurofibromatosis type 1 (NF1).
Founded by the Children’s Tumor Foundation and Deep Science Ventures, CureAge brings together patients, scientists, and entrepreneurs to build the first curative therapy for NF1 and other Schwann cell-related disorders.
Company Details
- Employees
- 5
- Founded
- 2024
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.cureagetx.com
- Keywords
- in running clinical trials for NF..
Cureage Therapeutics Questions
Cureage Therapeutics's website is http://www.cureagetx.com
Cureage Therapeutics's LinkedIn profile is https://www.linkedin.com/company/cureage-therapeutics
Cureage Therapeutics has
5 employees.
View email and phone details for 5
employees at Cureage Therapeutics.
Cureage Therapeutics's industry is
Biotechnology Research
Cureage Therapeutics's top competitors are
Plurify,
Panthura,
Children's Tumor Foundation,
Kasvu Therapeutics,
Antiverse,
Neobe Therapeutics,
Oligotune,
Noga Therapeutics,
Deep Science Ventures,
Encoded Therapeutics Inc..
Cureage Therapeutics's categories are Biotechnology Research
Cureage Therapeutics's founding year is 2024
